YCBD.AMEXCbdmd, INC

8-K: cbdMD Acquires 'CBD MD' Trademark, Amends Debt Agreement

Sentiment:

Material Definitive Agreement


cbdMD, Inc. has acquired the 'CBD MD' trademark, settled litigation, and amended its debt agreement with institutional investors.

Summary

  • cbdMD, Inc. entered into an agreement on August 23, 2024, to acquire the 'CBD MD' trademark from Majik Medicine, LLC.
  • The company paid Majik $100,000 upfront and will pay an additional $50,000 annually for four years.
  • cbdMD also issued 75,000 shares of common stock to Majik and will issue an additional 50,000 shares in one year.
  • A five-year consulting agreement was established with Majik, where they will receive a 15% commission on new sales to a specific wholesale customer base.
  • The company amended its debt agreement to include the acquired trademark as a permitted lien and the additional payments as permitted indebtedness.
  • The settlement also includes the dismissal of ongoing litigation between the two companies.

Sentiment

Score: 7

Explanation: The document presents a positive strategic move with the acquisition of a trademark and settlement of litigation, but there are some financial obligations and risks associated with the consulting agreement.

Positives

  • The acquisition of the 'CBD MD' trademark strengthens the company's intellectual property portfolio.
  • The settlement avoids further costly litigation.
  • The consulting agreement provides access to a new wholesale customer base with potential for increased sales.
  • The amendment to the debt agreement provides flexibility for the company's financial obligations.

Negatives

  • The company is obligated to make additional payments of $50,000 annually for four years to Majik.
  • The company is issuing 125,000 shares of common stock to Majik, which could dilute existing shareholders.
  • Failure to make the additional payments will result in the reassignment of the trademark to Majik.

Risks

  • The success of the consulting agreement depends on Majik's ability to generate new sales.
  • The company's ability to meet the requirements under the consulting agreement is not guaranteed.
  • The wholesale customer base may not accept the company's products.
  • Consumers may be hesitant to change their purchasing habits.

Future Outlook

The company anticipates positive potential from the consulting agreement and believes securing the Limited Mark will enhance its IP portfolio and avoid further litigation costs. However, these are forward-looking statements and actual results may vary.

Management Comments

  • The Company believes securing the Limited Mark enhances the Company's overall IP portfolio.
  • The Company believes the consulting agreement will help them access a new wholesale customer base.

Industry Context

The acquisition of the trademark and settlement of litigation are strategic moves to protect the company's brand and reduce legal expenses. The consulting agreement is an attempt to expand into a new market segment, which is a common strategy in the competitive CBD industry.

Comparison to Industry Standards

  • Many companies in the CBD industry face challenges with trademark protection and litigation, making this acquisition a common strategic move.
  • Consulting agreements with commission-based incentives are a common method for companies to expand their sales reach.
  • The financial terms of the acquisition are within the range of similar transactions in the industry, although the specific value of the trademark is not disclosed.

Legal Proceedings

  • The company and Majik agreed to jointly execute and file a voluntary dismissal with prejudice for the proceedings relating to the Majik Claims.

Stakeholder Impact

  • Shareholders may experience dilution due to the issuance of new shares.
  • The company's brand and intellectual property portfolio will be strengthened.
  • The company may see increased sales through the new wholesale customer base.
  • The company will incur additional financial obligations through the annual payments and consulting agreement.

Next Steps

  • The company will make annual payments of $50,000 to Majik for the next four years.
  • The company will issue 50,000 additional shares of common stock to Majik in one year.
  • Majik will provide consulting services to solicit and refer a specific business vertical wholesale customer base.
  • The company will work to integrate the acquired trademark into its brand portfolio.

Key Dates

DateDescription
2019-04CBD Industries, LLC filed a cancellation proceeding against Majik Medicine, LLC.
2024-01-30Original issuance date of the 8% Senior Secured Original Issue 20% Discount Convertible Promissory Notes.
2024-08-23Effective date of the Amendment and Purchase Agreement.
2025-08-23One-year anniversary of the Purchase Agreement, additional 50,000 shares of common stock to be issued to Majik.

Keywords

trademark, acquisition, settlement, litigation, debt, consulting, wholesale, intellectual property, common stock, commission

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.